These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 15047837)
1. Bovine herpesvirus tegument protein VP22 enhances thymidine kinase/ganciclovir suicide gene therapy for neuroblastomas compared to herpes simplex virus VP22. Qiu Z; Harms JS; Zhu J; Splitter GA J Virol; 2004 Apr; 78(8):4224-33. PubMed ID: 15047837 [TBL] [Abstract][Full Text] [Related]
2. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death. Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113 [TBL] [Abstract][Full Text] [Related]
3. [Tegument viral protein 22 enhanced cell-killing effect of the herpes simplex virus thymidine kinase/ganciclovir system on ovarian cancer in vivo]. Kong BH; Wang WX; Liu CS; Ma DX; Qu X Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):195-8. PubMed ID: 12885362 [TBL] [Abstract][Full Text] [Related]
4. Bovine herpesvirus VP22 induces apoptosis in neuroblastoma cells by upregulating the expression ratio of Bax to Bcl-2. Qiu Z; Zhu J; Harms JS; Friedrichsen J; Splitter GA Hum Gene Ther; 2005 Jan; 16(1):101-8. PubMed ID: 15703493 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer. Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977 [TBL] [Abstract][Full Text] [Related]
6. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct. Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279 [TBL] [Abstract][Full Text] [Related]
7. A designed equine herpes thymidine kinase (EHV4 TK) variant improves ganciclovir-induced cell-killing. McSorley T; Ort S; Monnerjahn C; Konrad M Biochem Pharmacol; 2014 Feb; 87(3):435-44. PubMed ID: 24316433 [TBL] [Abstract][Full Text] [Related]
8. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. Harms JS; Ren X; Oliveira SC; Splitter GA J Virol; 2000 Apr; 74(7):3301-12. PubMed ID: 10708447 [TBL] [Abstract][Full Text] [Related]
9. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Dilber MS; Phelan A; Aints A; Mohamed AJ; Elliott G; Smith CI; O'Hare P Gene Ther; 1999 Jan; 6(1):12-21. PubMed ID: 10341871 [TBL] [Abstract][Full Text] [Related]
10. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection. Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525 [TBL] [Abstract][Full Text] [Related]
11. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice]. Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412 [TBL] [Abstract][Full Text] [Related]
12. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
13. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase. Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008 [TBL] [Abstract][Full Text] [Related]
14. Fusion of herpes simplex virus thymidine kinase to VP22 does not result in intercellular trafficking of the protein. Beerens AM; Rots MG; de Vries EF; Haisma HJ Int J Mol Med; 2007 May; 19(5):841-9. PubMed ID: 17390091 [TBL] [Abstract][Full Text] [Related]
15. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models. Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas. Azatian A; Yu H; Dai W; Schneiders FI; Botelho NK; Lord RV J Gastrointest Surg; 2009 Jun; 13(6):1044-51. PubMed ID: 19277794 [TBL] [Abstract][Full Text] [Related]
18. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir. Zhou H; He Z; Wang C; Xie T; Liu L; Liu C; Song F; Ma Y Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275821 [TBL] [Abstract][Full Text] [Related]
19. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines]. Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864 [TBL] [Abstract][Full Text] [Related]